📰 Anders Ullman News
Anders Ullman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anders Ullman. Real-time updates on events, politics, business and more.
April 4, 2024
/PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the...
June 19, 2023
Changes to Sobis management 19 June, 2023 14:45 Tony Hoos, Head of R&D and Medical Affairs , and Chief Medical Officer , is leaving... | June 19, 2023
May 9, 2023
/PRNewswire/ -- The Sobi® AGM was convened today on 9 May 2023. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows:...
May 9, 2023
STOCKHOLM, May 9, 2023 /PRNewswire/ -- The Sobi® AGM was convened today on 9 May 2023. At the AGM, the shareholders, in accordance with the proposed resolutions, resolved as follows: Adoption
March 30, 2023
The shareholders in Swedish Orphan Biovitrum AB Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting , to be held on Tuesday, 9 May 2023 at 15.00 at IVA Konferenscenter, Grev... | March 30, 2023
March 27, 2023
You efficacy and point and were highly statistically significant, which of course is the first thing. 0:0:6.780 --> 0:0:37.30 Peter... | March 27, 2023
March 21, 2023
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...
March 21, 2023
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...
March 21, 2023
/PRNewswire/ -- Selecta Biosciences, Inc. (NASDAQ: SELB) and Sobi®, today announced positive topline results from the Phase 3 DISSOLVE I & II placebo...
March 21, 2023
--75% of subjects in the DISSOLVE I extension phase on active treatment were responders through 12 months of...